Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2026-09-16 21:13:38 ET · period of report 2026-09-14 · accession 0001437749-26-030597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 21:13 | 2026-09-14 | PBYI | WILSON TROY EDWARD | Dir | S - Sale | $9.10 | -5,000 | 54.8K | -8% | -$45.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-14 | S | D | 5,000 | $9.10 | 54,750 | D | — | — | (F1) Adoption date of referenced 10b5-1(c) plan is: 06-15-2026 |